Ivan Odak

Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination

Joana Barros‐Martins, Swantje I. Hammerschmidt, Anne Cossmann et al. · Nature Medicine · 2021 · 455 citations · Full text

Reappearance of effector T cells is associated with recovery from COVID-19

Ivan Odak, Joana Barros‐Martins, Berislav Bošnjak et al. · EBioMedicine · 2020 · 147 citations · Full text

Single-Cell Transcriptomics Identifies the Adaptation of Scart1+ Vγ6+ T Cells to Skin Residency as Activated Effector Cells

Likai Tan, Inga Sandrock, Ivan Odak et al. · Cell Reports · 2019 · 120 citations · Full text

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Alina Tscherne, Jan Hendrik Schwarz, Cornelius Rohde et al. · Proceedings of the National Academy of Sciences · 2021 · 96 citations · Full text

A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood

Likai Tan, Alina Suzann Fichtner, Elena Bruni et al. · Science Immunology · 2021 · 92 citations · Full text